Literature DB >> 10935528

Ca2+ oscillation and c-fos gene expression induced via muscarinic acetylcholine receptor in human T- and B-cell lines.

T Fujii1, K Kawashima.   

Abstract

We previously reported that blood acetylcholine (ACh) mainly originates from T-lymphocytes and that muscarinic (Ms) ACh receptor mRNA is expressed in both T- and B-lymphocytes. In the present study, we used confocal laser scanning microscopy and fluo-3, a calcium-sensitive indicator, to investigate the effects of Ms-ACh receptor agonists on the intracellular free Ca2+ concentration ([Ca2+]i) in single cells from human T-cell (CEM) and B-cell (Daudi) lines, which we used as models of lymphocytes. In both cell lines, stimulation of Ms-ACh receptors with ACh (0.1-100 microM), bethanechol (100 microM), car-bachol (100 microM) or oxotremorine-M (Oxo-M; 0.1-100 microM) induced [Ca2+]i-dependent increases in fluo-3 fluorescence, which in the presence of extracellular Ca2+ were followed by oscillations in [Ca2+]i that persisted for at least 10 min. All effects were completely blocked by atropine (1 microM), an Ms-ACh receptor antagonist. In both cell lines Oxo-M (100 microM) up-regulated expression of c-fos mRNA in an extracellular Ca2+-dependent manner. Again, the effect was blocked by 1 microM atropine. These results provide the first evidence that stimulation of Ms-ACh receptors induces Ca2+ oscillations and up-regulates c-fos gene expression in T- and B-lymphocytes, which is consistent with the notion that ACh released from T-lymphocytes triggers nuclear signaling via Ms-ACh receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10935528     DOI: 10.1007/s002100000251

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  8 in total

1.  Upregulation of mRNA encoding the M5 muscarinic acetylcholine receptor in human T- and B-lymphocytes during immunological responses.

Authors:  Takeshi Fujii; Yoshihiro Watanabe; Tomoyuki Inoue; Koichiro Kawashima
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

Review 2.  Autonomic regulation of T-lymphocytes: Implications in cardiovascular disease.

Authors:  Safwan K Elkhatib; Adam J Case
Journal:  Pharmacol Res       Date:  2019-06-06       Impact factor: 7.658

3.  Interdicting Gq Activation in Airway Disease by Receptor-Dependent and Receptor-Independent Mechanisms.

Authors:  Richard Carr; Cynthia Koziol-White; Jie Zhang; Hong Lam; Steven S An; Gregory G Tall; Reynold A Panettieri; Jeffrey L Benovic
Journal:  Mol Pharmacol       Date:  2015-10-13       Impact factor: 4.436

4.  Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis.

Authors:  Yihe Chen; Sunil K Chauhan; Hyun Soo Lee; William Stevenson; Chris S Schaumburg; Zahra Sadrai; Daniel R Saban; Shilpa Kodati; Michael E Stern; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-03       Impact factor: 4.799

Review 5.  Muscarinic receptor signaling in the pathophysiology of asthma and COPD.

Authors:  Reinoud Gosens; Johan Zaagsma; Herman Meurs; Andrew J Halayko
Journal:  Respir Res       Date:  2006-05-09

6.  Cholinergic Machinery as Relevant Target in Acute Lymphoblastic T Leukemia.

Authors:  Oxana Dobrovinskaya; Georgina Valencia-Cruz; Luis Castro-Sánchez; Edgar O Bonales-Alatorre; Liliana Liñan-Rico; Igor Pottosin
Journal:  Front Pharmacol       Date:  2016-08-31       Impact factor: 5.810

Review 7.  Expression and Function of the Cholinergic System in Immune Cells.

Authors:  Takeshi Fujii; Masato Mashimo; Yasuhiro Moriwaki; Hidemi Misawa; Shiro Ono; Kazuhide Horiguchi; Koichiro Kawashima
Journal:  Front Immunol       Date:  2017-09-06       Impact factor: 7.561

Review 8.  Regulation of Immune Functions by Non-Neuronal Acetylcholine (ACh) via Muscarinic and Nicotinic ACh Receptors.

Authors:  Masato Mashimo; Yasuhiro Moriwaki; Hidemi Misawa; Koichiro Kawashima; Takeshi Fujii
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.